You are here :

2010 l Report

JULY 2010

A Successful Edition

The 17th edition of Cardiostim, the international congress of cardiac electrophysiology and technological developments, which took place in Nice, June 16 through 19, 2010, can claim to have been a brilliant success.
The all time record in congress participation confirmed the interest of medical scientists in a program enriched with highly attractive teaching material and promising themes, enabling the discovery of the most up-to-date technologies.
Philippe Ritter, President of Cardiostim, expressed his satisfaction in a preliminary report, which, in his views, “…..reflects the new qualitative and educational orientations requested by the scientific committee, forecasting a new era in the management of heart rhythm disorders, including the major innovations in this field, which were presented at Cardiostim”.

With a record 5,749 scientists participants (+9% compared with 2 years ago), from 95 countries, 200 sessions were held, during which 987 oral presentations were made and 456 posters were displayed.

While all themes offered to the congress participants were highly attended, ablation, cardiac resynchronization and implantable defibrillators were particularly sought-after, and drew record crowds.

Cardiostim 2010’s highlights were:
  • the management techniques of cardiac rhythm disorders, particularly with radiofrequency ablation and with remarkable progress made in the mapping and stimulation of atria and ventricles;
  • the new cardiac stimulation, resynchronization and implantable defibrillating devices equipped with new technology, including hemodynamic sensors;
  • the major contributions made by imaging, with new mapping techniques or digital cardiac modeling;
  • the progress made in telecardiology, offering an access to improved remote patient management with the transfer of medical information. The first results of the study by Professor Philippe Mabo (from the University Hospital of Rennes, France) of the remote follow-up of pacemaker recipients were presented at Cardiostim, confirming the clinical benefits conferred by this new technology.

The success of this edition of Cardiostim hinged, in part, on a more qualitative as well as educational approach to interventions.

With a view to enhance the quality of presentations, the scientific committee imposed a more stringent selection of abstracts (rejecting 45% of submissions this year), retaining the highest-level messages and attributing a higher value to the efforts contributed by medical investigators.

A second major factor of success were the EDUSTIM teaching sessions, dedicated to ablation and electrophysiology, confirming the appropriateness of Cardiostim’s decision to broaden the forum to concrete applications and offer more teaching based on clinical cases, enabling a return to the fundamental principles of cardiac electrophysiology.

For Philippe Ritter, President of Cardiostim, these first observations support the new orientation recommended by the committee. “We wished, this year, to open more space for teaching, and promote a larger number of debates, to give all participants a wider access to the new clinical knowledge that has become available. The first indications confirmed that this quest for teaching and scientific information was well received, enriching the daily practice of the participants”.

A third major factor of success of this last edition of Cardiostim hinged on the contributions made by industry and engineers who presented state-of-the-art material and latest technologic innovations, as well as interacted with medical experts who shared their clinical experiences.

We rewarded 3 major breakthroughs in the field of cardiac electrophysiology this year by attributing a brand new award for innovations.

The 1st prize went to “Home Monitoring R” by Biotronik Inc., a remote monitoring system for pacemaker recipients; the 2nd prize was attributed to “SonR” by the Sorin Group, a new hemodynamic sensor embedded in pacemakers and defibrillators; the 3rd prize was awarded to “Surescan pacing systems” by Medtronic Inc., the first pacing system which includes a lead compatible with magnetic resonance imaging.


From June 13 til 16, 2012

with the presentation of clinical cases, starting September 2010

Press access

Catherine Rouillé - Virginie Renouvin
Tél. +33 (0)1 49 74 42 01 -